Similar outcomes were seen with an intraperitoneal injection of HER2 CAR-T cells in PC due to gastric cancer, including prolonged animal survival and significantly slower tumor development compared to intraperitoneal administration of non-transduced T cells [127]. The gene discussed is ERBB2; the disease is gastric cancer.